Page last updated: 2024-09-05

tolvaptan and Nephrosclerosis

tolvaptan has been researched along with Nephrosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ishikawa, M; Ishimitsu, T; Kobayashi, N; Onoda, S; Sugiyama, F	1

Other Studies

1 other study(ies) available for tolvaptan and Nephrosclerosis

Article	Year
Renoprotective effect of vasopressin v2 receptor antagonist tolvaptan in Dahl rats with end-stage heart failure. International heart journal, 2013, Volume: 54, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Benzazepines; Chemokine CCL2; Chemokine CCL5; Drug Evaluation, Preclinical; Epithelial-Mesenchymal Transition; Heart Failure; Kidney Cortex; Male; MAP Kinase Signaling System; NADPH Oxidases; Nephrosclerosis; NF-kappa B; Oxidative Stress; Podocytes; Rats; Rats, Inbred Dahl; rho-Associated Kinases; Superoxides; Tolvaptan; Tumor Necrosis Factor-alpha	2013

Article

Year

Renoprotective effect of vasopressin v2 receptor antagonist tolvaptan in Dahl rats with end-stage heart failure.

International heart journal, 2013, Volume: 54, Issue:2

Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Benzazepines; Chemokine CCL2; Chemokine CCL5; Drug Evaluation, Preclinical; Epithelial-Mesenchymal Transition; Heart Failure; Kidney Cortex; Male; MAP Kinase Signaling System; NADPH Oxidases; Nephrosclerosis; NF-kappa B; Oxidative Stress; Podocytes; Rats; Rats, Inbred Dahl; rho-Associated Kinases; Superoxides; Tolvaptan; Tumor Necrosis Factor-alpha

2013